BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 3081317)

  • 41. Lirentelimab for severe and chronic forms of allergic conjunctivitis.
    Anesi SD; Tauber J; Nguyen QD; Chang P; Berdy GJ; Lin CC; Chu DS; Levine HT; Fernandez AD; Roy N; Asbell PA; Kantor AM; Chang AT; Singh B; Youngblood BA; Jeng BH; Jhanji V; Rasmussen HS; Foster CS
    J Allergy Clin Immunol; 2022 Sep; 150(3):631-639. PubMed ID: 35390403
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Disodium cromoglycate (Intal) in the treatment of vernal kerato-conjunctivitis.
    Easty D; Rice NS; Jones BR
    Trans Ophthalmol Soc U K (1962); 1971; 91():491-9. PubMed ID: 5004367
    [No Abstract]   [Full Text] [Related]  

  • 43. Comparison of efficacy of bromfenac sodium 0.1% ophthalmic solution and fluorometholone 0.02% ophthalmic suspension for the treatment of allergic conjunctivitis.
    Fujishima H; Fukagawa K; Takano Y; Tanaka M; Okamoto S; Miyazaki D; Yamada J; Fukushima A; Uchio E; Nakagawa Y
    J Ocul Pharmacol Ther; 2009 Jun; 25(3):265-70. PubMed ID: 19348602
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Allergic conjunctivitis].
    Del Río-Navarro BE; Sienra-Monge JJ; Castellanos A; Williams-Gotti MJ
    Bol Med Hosp Infant Mex; 1992 Apr; 49(4):201-4. PubMed ID: 1305389
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy and safety of lodoxamide 0.1% vs cromolyn sodium 4% in patients with vernal keratoconjunctivitis.
    Caldwell DR; Verin P; Hartwich-Young R; Meyer SM; Drake MM
    Am J Ophthalmol; 1992 Jun; 113(6):632-7. PubMed ID: 1598953
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vernal keratoconjunctivitis in an Israeli group of patients and its treatment with sodium cromoglycate.
    Baryishak YR; Zavaro A; Monselise M; Samra Z; Sompolinsky D
    Br J Ophthalmol; 1982 Feb; 66(2):118-22. PubMed ID: 6800400
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sodium cromoglycate in management of vernal and chronic allergic conjunctivitis.
    Hyvärinen L
    Int Ophthalmol; 1979 Feb; 1(2):129-33. PubMed ID: 121929
    [No Abstract]   [Full Text] [Related]  

  • 48. A critical look at ocular allergy drugs.
    Joseph Titi M
    Am Fam Physician; 1996 Jun; 53(8):2637-42, 2645-6. PubMed ID: 8644576
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Topical tacrolimus for the treatment of severe allergic keratoconjunctivitis in children.
    Liendo VL; Vola ME; Barreiro TP; Wakamatsu TH; Gomes JÁP; Santos MSD
    Arq Bras Oftalmol; 2017; 80(4):211-214. PubMed ID: 28954018
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Levocabastine. An update of its pharmacology, clinical efficacy and tolerability in the topical treatment of allergic rhinitis and conjunctivitis.
    Noble S; McTavish D
    Drugs; 1995 Dec; 50(6):1032-49. PubMed ID: 8612470
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy of nedocromil sodium and cromolyn sodium in an experimental model of ocular allergy.
    Calonge M; Montero JA; Herreras JM; Ramón JJ; Pastor JC
    Ann Allergy Asthma Immunol; 1996 Aug; 77(2):124-30. PubMed ID: 8760778
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of topical cromolyn sodium in the treatment of vernal keratoconjunctivitis.
    Foster CS
    Ophthalmology; 1988 Feb; 95(2):194-201. PubMed ID: 3140155
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treating the ocular component of allergic rhinoconjunctivitis and related eye disorders.
    Bielory L; Katelaris CH; Lightman S; Naclerio RM
    MedGenMed; 2007 Aug; 9(3):35. PubMed ID: 18092041
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A clinical comparison of topical clobetasone butyrate and sodium cromoglycate in allergic conjunctivitis.
    Frankland AW; Walker SR
    Clin Allergy; 1981 Sep; 11(5):473-8. PubMed ID: 6797754
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An unexpected reaction towards disodium cromoglycate.
    Skarpaas IJ
    Allergy; 1987 May; 42(4):318-9. PubMed ID: 3113281
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Medical therapy for ocular allergy.
    Trocme SD; Raizman MB; Bartley GB
    Mayo Clin Proc; 1992 Jun; 67(6):557-65. PubMed ID: 1359206
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tacrolimus eye drops as monotherapy for vernal keratoconjunctivitis: a randomized controlled trial.
    Müller EG; Santos MSD; Freitas D; Gomes JÁP; Belfort R
    Arq Bras Oftalmol; 2017 Jun; 80(3):154-158. PubMed ID: 28832739
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of lodoxamide and disodium cromoglycate on tear eosinophil cationic protein in vernal keratoconjunctivitis.
    Leonardi A; Borghesan F; Avarello A; Plebani M; Secchi AG
    Br J Ophthalmol; 1997 Jan; 81(1):23-6. PubMed ID: 9135403
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of vernal keratoconjunctivitis: a retrospective clinical case study. Wallace F. Molinari Ocular Pharmacology Award.
    Coutu RB
    Optom Vis Sci; 1991 Jul; 68(7):561-4. PubMed ID: 1923330
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [N-acetyl-aspartylglutamic acid eye drops in allergic-type conjuctivitis. Double-blind comparative clinical study].
    Bonnet M; Ducournau D; Lumbroso P; Serpin G
    J Fr Ophtalmol; 1985; 8(8-9):573-8. PubMed ID: 3936869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.